Factual end-of-day data for NATCOPHARM: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 2,33,109 shares was well below the 20-day average (0.5×).
NATCOPHARM touched a fresh 52-week low in this session.
NATCOPHARM's delivery share of 48.7% was below its 20-day average of 52.9%.
| Date | Close | Change | Volume | Delivered qty | Delivery % |
|---|---|---|---|---|---|
| 9 Oct 2026 | ₹789.40 | -0.75% | 2,33,109 | 1,13,494 | 48.7% |
| 8 Oct 2026 | ₹795.40 | -1.81% | 3,12,124 | 1,68,321 | 53.9% |
| 7 Oct 2026 | ₹810.10 | -1.65% | 4,99,574 | 2,77,605 | 55.6% |
| 6 Oct 2026 | ₹823.65 | +0.26% | 2,25,113 | 1,39,297 | 61.9% |
| 5 Oct 2026 | ₹821.50 | +0.02% | 5,71,712 | 3,20,181 | 56.0% |
| 1 Oct 2026 | ₹821.30 | -0.75% | 7,17,435 | 3,97,188 | 55.4% |
| 30 Sep 2026 | ₹827.50 | -1.85% | 6,15,035 | 4,01,751 | 65.3% |
| 29 Sep 2026 | ₹843.10 | +1.76% | 6,36,356 | 2,93,787 | 46.2% |
| 28 Sep 2026 | ₹828.55 | -1.28% | 5,02,079 | 2,74,185 | 54.6% |
| 25 Sep 2026 | ₹839.30 | -0.32% | 3,69,981 | 1,61,736 | 43.7% |
| 24 Sep 2026 | ₹842.00 | +0.53% | 5,24,314 | 2,06,959 | 39.5% |
| 23 Sep 2026 | ₹837.60 | +2.77% | 6,50,820 | 3,29,873 | 50.7% |
| 22 Sep 2026 | ₹815.05 | -0.15% | 6,19,357 | 3,41,829 | 55.2% |
| 21 Sep 2026 | ₹816.30 | +0.36% | 4,51,347 | 2,72,852 | 60.5% |
| 18 Sep 2026 | ₹813.40 | -0.59% | 4,89,351 | 2,97,976 | 60.9% |
| 17 Sep 2026 | ₹818.25 | +0.61% | 3,40,518 | 1,65,576 | 48.6% |
| 16 Sep 2026 | ₹813.30 | -0.71% | 4,92,595 | 2,50,779 | 50.9% |
| 15 Sep 2026 | ₹819.15 | +0.47% | 4,34,634 | 2,10,940 | 48.5% |
| 11 Sep 2026 | ₹815.35 | -0.40% | 5,67,956 | 2,54,682 | 57.4% |
| 10 Sep 2026 | ₹818.65 | -0.93% | 2,36,487 | 1,27,636 | 54.0% |
Compare with delivery percentage for all NSE stocks.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume.
Large-trade volume split: 1,000 shares on the buy side vs 0 on the sell side.
Largest single buy-side trade: 500 shares at ₹799.80.
| Indicator | Reading (9 Oct 2026) |
|---|---|
| RSI (14) | 30.9 |
| 50-day EMA | ₹854.69 — close is below |
| 200-day EMA | ₹909.23 — close is below |
| SuperTrend (10, 3) | ₹861.25 — close is below the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
NATCOPHARM is a mid-cap NSE stock in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹16,221 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 9 Oct 2026, 48.7% of NATCOPHARM's traded volume was marked for delivery (1,13,494 shares delivered). The 20-day average delivery is 52.9%.
NATCOPHARM closed at ₹789.40 on 9 Oct 2026 (-0.75% vs the previous close).
52-week high ₹1,226.80, 52-week low ₹787.45. The latest close is -35.65% from the 52-week high.